2-Methyl-5-(1-methyl-pyrrolidin-2-yl)-pyridine

ID: ALA294757

Chembl Id: CHEMBL294757

Cas Number: 101540-79-8

PubChem CID: 5020711

Max Phase: Preclinical

Molecular Formula: C11H16N2

Molecular Weight: 176.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C2CCCN2C)cn1

Standard InChI:  InChI=1S/C11H16N2/c1-9-5-6-10(8-12-9)11-4-3-7-13(11)2/h5-6,8,11H,3-4,7H2,1-2H3

Standard InChI Key:  SWNIAVIKMKSDBJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Chrna3 Neuronal acetylcholine receptor (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrnb2 Neuronal nicotinic acetylcholine receptor (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 176.26Molecular Weight (Monoisotopic): 176.1313AlogP: 2.16#Rotatable Bonds: 1
Polar Surface Area: 16.13Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.50CX LogP: 1.29CX LogD: 0.16
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.65Np Likeness Score: -0.33

References

1. Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA..  (2002)  A comparison of the binding of three series of nicotinic ligands.,  12  (15): [PMID:12113825] [10.1016/s0960-894x(02)00298-6]
2. Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA..  (2002)  (-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine.,  12  (20): [PMID:12270194] [10.1016/s0960-894x(02)00614-5]
3. Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA..  (2005)  6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.,  15  (13): [PMID:15925512] [10.1016/j.bmcl.2005.04.072]
4. Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA..  (2005)  3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.,  15  (19): [PMID:16039854] [10.1016/j.bmcl.2005.06.053]

Source